Literature DB >> 16937283

Genetic prognostic index influences patient outcome for node-positive breast cancer.

Shin-Ichi Asaka1, Takashi Fujimoto, Junko Akaishi, Kenji Ogawa, Masamitsu Onda.   

Abstract

PURPOSE: To establish a novel genetic prognostic index among node-positive breast cancer patients.
METHODS: Using a cDNA microarray, the gene expression profiles of 20 primary breast cancers that had metastasis to four or more axillary lymph nodes were examined. Ten patients survived disease-free for more than 5 years (5S), while ten patients died of breast cancer within 5 years of surgery (5D).
RESULTS: A set of genes characterizing each group was identified. Sixteen genes were underexpressed in 5D compared to 5S, and 15 genes were underexpressed in 5S in comparison to 5D. The prognostic index (PI) was established, which could predict the postoperative outcome with five genes that were commonly underexpressed in the 5D group; these genes encoded granulin (GRN), heat shock 90 kDa protein 1 beta (HSPCB), large tumor suppressor homolog 1 (LATS1), valosin-containing protein (VCP), and LIM-and-SH3 protein1 (LASP1).
CONCLUSION: These five genes might play an important role in deciding the behavior of node-positive breast cancer. The PI system could thus predict the prognosis of node-positive breast cancer, and might therefore be able to provide valuable information for the prognosis of breast cancer patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16937283     DOI: 10.1007/s00595-006-3261-2

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  56 in total

1.  Modulation of Akt kinase activity by binding to Hsp90.

Authors:  S Sato; N Fujita; T Tsuruo
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-26       Impact factor: 11.205

2.  Intratumoral heterogeneity for hsp90beta mRNA levels in a breast cancer cell line.

Authors:  C Luparello; A Noël; I Pucci-Minafra
Journal:  DNA Cell Biol       Date:  1997-10       Impact factor: 3.311

3.  Distinctive gene expression patterns in human mammary epithelial cells and breast cancers.

Authors:  C M Perou; S S Jeffrey; M van de Rijn; C A Rees; M B Eisen; D T Ross; A Pergamenschikov; C F Williams; S X Zhu; J C Lee; D Lashkari; D Shalon; P O Brown; D Botstein
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

4.  Detection of frequent allelic loss of 6q23-q25.2 in microdissected human breast cancer tissues.

Authors:  H Fujii; W Zhou; E Gabrielson
Journal:  Genes Chromosomes Cancer       Date:  1996-05       Impact factor: 5.006

5.  Ansamycin antibiotics inhibit Akt activation and cyclin D expression in breast cancer cells that overexpress HER2.

Authors:  Andrea D Basso; David B Solit; Pamela N Munster; Neal Rosen
Journal:  Oncogene       Date:  2002-02-14       Impact factor: 9.867

6.  Stimulation of PC cell-derived growth factor (epithelin/granulin precursor) expression by estradiol in human breast cancer cells.

Authors:  R Lu; G Serrero
Journal:  Biochem Biophys Res Commun       Date:  1999-03-05       Impact factor: 3.575

7.  Actin binding of human LIM and SH3 protein is regulated by cGMP- and cAMP-dependent protein kinase phosphorylation on serine 146.

Authors:  Elke Butt; Stepan Gambaryan; Nina Göttfert; Annette Galler; Katrin Marcus; Helmut E Meyer
Journal:  J Biol Chem       Date:  2003-02-05       Impact factor: 5.157

8.  Heat shock proteins are differentially expressed in human gastrointestinal cancers.

Authors:  J A Ehrenfried; B E Herron; C M Townsend; B M Evers
Journal:  Surg Oncol       Date:  1995-08       Impact factor: 3.279

9.  Gene expression patterns as marker for 5-year postoperative prognosis of primary breast cancers.

Authors:  Masamitsu Onda; Mitsuru Emi; Hisaki Nagai; Takemitsu Nagahata; Kouji Tsumagari; Takashi Fujimoto; Futoshi Akiyama; Goi Sakamoto; Masujirou Makita; Fujio Kasumi; Yoshio Miki; Toshihiro Tanaka; Tatsuhiko Tsunoda; Yusuke Nakamura
Journal:  J Cancer Res Clin Oncol       Date:  2004-07-03       Impact factor: 4.553

10.  Clinical and biological significance of HSP89 alpha in human breast cancer.

Authors:  A Jameel; R A Skilton; T A Campbell; S K Chander; R C Coombes; Y A Luqmani
Journal:  Int J Cancer       Date:  1992-02-01       Impact factor: 7.396

View more
  13 in total

1.  IRX1 hypomethylation promotes osteosarcoma metastasis via induction of CXCL14/NF-κB signaling.

Authors:  Jinchang Lu; Guohui Song; Qinglian Tang; Changye Zou; Feng Han; Zhiqiang Zhao; Bicheng Yong; Junqiang Yin; Huaiyuan Xu; Xianbiao Xie; Tiebang Kang; YingLee Lam; Huiling Yang; Jingnan Shen; Jin Wang
Journal:  J Clin Invest       Date:  2015-03-30       Impact factor: 14.808

2.  IRX1 hypermethylation promotes heart failure by inhibiting CXCL14 expression.

Authors:  Longhuan Zeng; Nanyuan Gu; Jiayi Chen; Guangyong Jin; Yongke Zheng
Journal:  Cell Cycle       Date:  2019-10-22       Impact factor: 4.534

Review 3.  The complexities of p97 function in health and disease.

Authors:  Eli Chapman; Anastasia N Fry; MinJin Kang
Journal:  Mol Biosyst       Date:  2010-12-14

4.  The Transitional Endoplasmic Reticulum ATPase p97 Regulates the Alternative Nuclear Factor NF-κB Signaling via Partial Degradation of the NF-κB Subunit p100.

Authors:  Zhao Zhang; Yanyan Wang; Chuanchuan Li; Zhubing Shi; Qian Hao; Wenjia Wang; Xiaomin Song; Yun Zhao; Shi Jiao; Zhaocai Zhou
Journal:  J Biol Chem       Date:  2015-06-25       Impact factor: 5.157

5.  Prediction of outcome of patients with metastatic breast cancer: evaluation with prognostic factors and Nottingham prognostic index.

Authors:  Mu-Tai Liu; Wen-Tao Huang; Ai-Yih Wang; Chia-Chun Huang; Chao-Yuan Huang; Tung-Hao Chang; Chu-Pin Pi; Hao-Han Yang
Journal:  Support Care Cancer       Date:  2009-11-11       Impact factor: 3.603

6.  Lasp1 gene disruption is linked to enhanced cell migration and tumor formation.

Authors:  Han Zhang; Xunsheng Chen; Wendy B Bollag; Roni J Bollag; Daniel J Sheehan; Catherine S Chew
Journal:  Physiol Genomics       Date:  2009-06-16       Impact factor: 3.107

7.  Aberrant V(D)J recombination is not required for rapid development of H2ax/p53-deficient thymic lymphomas with clonal translocations.

Authors:  Craig H Bassing; Sheila Ranganath; Mike Murphy; Velibor Savic; Meagan Gleason; Frederick W Alt
Journal:  Blood       Date:  2007-09-13       Impact factor: 22.113

8.  Nuclear localization and cytosolic overexpression of LASP-1 correlates with tumor size and nodal-positivity of human breast carcinoma.

Authors:  Thomas G P Grunewald; Ulrike Kammerer; Michaela Kapp; Matthias Eck; Johannes Dietl; Elke Butt; Arnd Honig
Journal:  BMC Cancer       Date:  2007-10-23       Impact factor: 4.430

Review 9.  Inhibitors of the AAA+ chaperone p97.

Authors:  Eli Chapman; Nick Maksim; Fabian de la Cruz; James J La Clair
Journal:  Molecules       Date:  2015-02-12       Impact factor: 4.411

10.  The LIM and SH3 domain protein family: structural proteins or signal transducers or both?

Authors:  Thomas G P Grunewald; Elke Butt
Journal:  Mol Cancer       Date:  2008-04-17       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.